BOC has no records of 2 luxury cars acquired by Pharmally execs, senators learn | Inquirer News

BOC has no records of 2 luxury cars acquired by Pharmally execs, senators learn

/ 10:28 PM November 10, 2021

Gordon questions luxury cars allegedly owned by Pharmally execs

Slide presented by Sen. Richard Gordon. (Photo courtesy of Gordon’s office)

MANILA, Philippines — Two luxury cars acquired by officials of Pharmally Pharmaceutical Corp. have no records with the Bureau of Customs (BOC), senators learned Wednesday.

During the Senate plenary deliberations on the 2022 budget, Sen. Sonny Angara relayed to other senators information from BOC Commissioner Rey Leonardo Guerrero about the luxury vehicles registered to Pharmally executives.

ADVERTISEMENT

“According to him [Guerrero], all of the vehicles have appeared in their records as having gone through the process — the legal processes — and the payment of taxes and duties except for the 2021 Porsche 911 Turbo S and the 2021 Lexus RCF,” Angara said.

FEATURED STORIES

Angara, chairman of the Senate finance committee, was defending the budget of the Department of Finance, under which is the BOC.

The information on the vehicles were requested by Sen. Richard Gordon, who chairs the blue ribbon panel.

The Porsche was registered to Pharmally corporate secretary and treasurer Mohit DarganI and  the Lexus was registered to Pharmally director Linconn Ong, according to Land Transportation Office records presented by Gordon in one of the blue ribbon committee hearings.

READ: Gordon questions luxury cars allegedly owned by Pharmally execs

The blue ribbon panel has been investigating the government’s purchases of medical goods, including allegedly overpriced face masks, face shields, and other supplies, at the height of the pandemic last year.

In the course of the inquiry, senators repeatedly questioned the Department of Health’s transfer of P42 billion to the Procurement Service of the Department of Budget and Management for the purchase of pandemic response supplies.

ADVERTISEMENT

A portion of this amount went to over P8.6 billion worth of contracts awarded to Pharmally. Senators doubted the financial capacity of the firm since it was only established in 2019 with a small capital of P625,000 when it secured the supply deals.

READ: Mago absent as senators pound on PS-DBM ‘favoritism’

ATM


Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: BOC

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.